Bangladesh inks MoU with Indian company for COVID-19 vaccine
The Bangladesh government has signed a Memorandum of Understanding (MoU) with Serum Institute of India Pvt Limited and Beximco Pharmaceuticals Ltd (BPL) to get 30 million dodges of SARS-Cov-2 AZD 1222 (Oxford/Astrazeneca Vaccine)
The Bangladesh government has signed a Memorandum of Understanding (MoU) with Serum Institute of India Pvt Limited and Beximco Pharmaceuticals Ltd (BPL) to get 30 million dodges of SARS-Cov-2 AZD 1222 (Oxford/Astrazeneca Vaccine).
Additional Secretary to the Health Service Division Mostafa Kamal and representatives from Serum Institute and Beximco Pharmaceuticals Limited of Bangladesh signed the MoU at the Health Ministry in presence of Health Minister Zahid Maleque in Dhaka on Thursday.
As per the MoU, Serum institute will provide SARS-Cov-2 AZD 1222 (Oxford/Astrazeneca Vaccine) to Beximco Pharmaceuticals Ltd (BPL).
https://www.dhakatribune.com/health/coronavirus/2020/11/05/govt-inks-mou-to-get-30-million-covid-19-vaccines
Post a Comment